Baricitinib for the treatment of cutaneous dermatomyositis: A prospective, open-label study

被引：15
|
作者：
Zhao, Qian [1 ]
Zhu, Zicong [1 ]
Fu, Qiaoyu [1 ]
Shih, Yanting [1 ]
Wu, Dan [1 ]
Chen, Lihong [1 ]
Zheng, Jie [1 ]
Cao, Hua [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Dermatol, 197 Ruijin 2nd Rd, Shanghai, Peoples R China
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 06期
基金：
中国国家自然科学基金;
关键词：
autoimmune skin disease; baricitinib; CDASI; dermatomyositis; JAK inhibitors;
D O I：
10.1016/j.jaad.2022.08.025
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：1374 / 1376
页数：4
相关论文
共 50 条
  • [41] Fecal microbiota transplantation for treatment of slow transit constipation: a prospective open-label study
    Tian, H. L.
    Ding, C.
    Ge, X. L.
    Gong, J. F.
    Li, N.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 22 - 22
  • [42] Regarding "A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency"
    Lee, Byung-Boong
    JOURNAL OF VASCULAR SURGERY, 2010, 52 (02) : 533 - 533
  • [43] Transcutaneous Supraorbital Stimulation as a Preventive Treatment for Chronic Migraine: A Prospective, Open-Label Study
    Ordas, Carlos M.
    Cuadrado, Maria L.
    Pareja, Juan A.
    de-las-Casas-Camara, Gonzalo
    Gomez-Vicente, Lidia
    Torres-Gaona, Gustavo
    Venegas-Perez, Begone
    Alvarez-Marino, Beatriz
    Diez Barrio, Ana
    Pardo-Moreno, Javier
    PAIN MEDICINE, 2020, 21 (02) : 415 - 422
  • [44] Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study
    Agarwala, S
    Jain, D
    Joshi, VR
    Sule, A
    RHEUMATOLOGY, 2005, 44 (03) : 352 - 359
  • [45] A Prospective, Open-Label Pilot Study of Concurrent Male Partner Treatment for Bacterial Vaginosis
    Plummer, Erica L.
    Vodstrcil, Lenka A.
    Doyle, Michelle
    Danielewski, Jennifer A.
    Murray, Gerald L.
    Fehler, Glenda
    Fairley, Christopher K.
    Bulach, Dieter M.
    Garland, Suzanne M.
    Chow, Eric P. F.
    Hocking, Jane S.
    Bradshaw, Catriona S.
    MBIO, 2021, 12 (05):
  • [46] Comment on: A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis
    Sato, Takeo
    Inokuma, Shigeko
    RHEUMATOLOGY, 2010, 49 (08) : 1607 - 1607
  • [47] Tapentadol in cancer pain management: a prospective open-label study
    Mercadante, Sebastiano
    Porzio, Giampiero
    Ferrera, Patrizia
    Aielli, Federica
    Adile, Claudio
    Ficorella, Corrado
    Giarratano, Antonello
    Casuccio, Alessandra
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (11) : 1775 - 1779
  • [48] A prospective open-label study of aripiprazole in fragile X syndrome
    Erickson, Craig A.
    Stigler, Kimberly A.
    Wink, Logan K.
    Mullett, Jennifer E.
    Kohn, Arlene
    Posey, David J.
    McDougle, Christopher J.
    PSYCHOPHARMACOLOGY, 2011, 216 (01) : 85 - 90
  • [49] Intralesional measles, mumps and rubella vaccine for the treatment of multiple and recalcitrant nongenital cutaneous warts in children: a prospective, uncontrolled open-label study
    Parmar, N.
    Kuruvila, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 : 160 - 160
  • [50] A prospective open-label study of aripiprazole in fragile X syndrome
    Craig A. Erickson
    Kimberly A. Stigler
    Logan K. Wink
    Jennifer E. Mullett
    Arlene Kohn
    David J. Posey
    Christopher J. McDougle
    Psychopharmacology, 2011, 216 : 85 - 90
12345